Yahoo Finance

FDA Approves CardiAMP® Heart Failure II Protocol Amendment to Use Proprietary Cell Population Analysis Screening to Define Treatment

SUNNYVALE, Calif., Aug. 21, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary ...
Yahoo Finance

Aardvark Therapeutics Announces FDA Alignment on Protocol Amendment Expanding Phase 3 HERO Trial Population for Prader-Willi Syndrome

SAN DIEGO, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics ...
Investing

FDA approves enhanced dosing protocol for BioCardia trial

SUNNYVALE, Calif. - BioCardia, Inc. (Nasdaq: NASDAQ:BCDA), a biotechnology firm specializing in cellular therapies for cardiovascular and pulmonary diseases, announced today that the U.S. Food and ...
finanzen.at

Diamyd Medical Secures FDA Alignment To Accelerate Phase 3 Trial Readout In Type 1 Diabetes

Diamyd Medical announced that it has reached alignment with the U.S. Food and Drug Administration to accelerate the primary efficacy ...
PR Newswire

AnBogen Therapeutics Receives Approval from U.S. FDA for Phase Ib/II Protocol Amendment for ABT-101

An oral Tyrosine Kinase Inhibitor of HER2 Exon20 Insertion, for the Treatment of Non-Small Cell Lung Cancer TAIPEI, Sept. 13, 2022 /PRNewswire/ -- AnBogen Therapeutics, a clinical-stage biotech ...
Seeking Alpha

CNS Pharmaceuticals Receives Approval from U.S. FDA for Protocol Amendment to Ongoing Potentially Pivotal Global Trial Evaluating Berubicin for the Treatment of GBM

HOUSTON, June 23, 2022 /PRNewswire/ -- CNS Pharmaceuticals, Inc. (CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and ...
Pharmabiz

US FDA approves Aethlon Medical’s Hemopurifier Covid-19 study protocol amendment

Aethlon Medical, Inc., a medical therapeutic company, announced that the US Food and Drug Administration (FDA) has approved an amendment to the protocol of its ongoing clinical trial investigating the ...
London South East

Pediatric Amendment to Clinical Protocol

Amendment to Clinical Protocol for HG-CT-1 to Include Pediatric Patients with R/R AML Hemogenyx Pharmaceuticals plc (LSE:HEMO) is pleased to announce that it has filed an amendment to the clinical ...